Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 450572, 16 pages
http://dx.doi.org/10.1155/2014/450572
Research Article

Synergistic Effect between Cryptotanshinone and Antibiotics against Clinic Methicillin and Vancomycin-Resistant Staphylococcus aureus

1Department of Research Development, Institute of Jinan Red Ginseng, Jinan, Republic of Korea
2Department of Oriental Medicine Resources, College of Environmental and Bioresource Sciences, Chonbuk National University, Republic of Korea
3Department of Dental Hygiene, Daegu Health College, Daegu, Republic of Korea
4Department of Nursing, Dong-eui University, Republic of Korea

Received 25 November 2013; Revised 6 February 2014; Accepted 18 February 2014; Published 24 March 2014

Academic Editor: Tai-Long Pan

Copyright © 2014 Jeong-Dan Cha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. R. Corey, “Staphylococcus aureusbloodstream infections: definitions and treatment,” Clinical Infectious Diseases, vol. 48, no. 4, pp. S254–S259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. A. Petti and V. G. Fowler Jr., “Staphylococcus aureus bacteremia and endocarditis,” Cardiology Clinics, vol. 21, no. 2, pp. 219–233, 2003. View at Google Scholar · View at Scopus
  3. A. Malm, A. Biernasiuk, R. Łoś et al., “Slime production and cell surface hydrophobicity of nasopharyngeal and skin staphylococci isolated from healthy people,” Polish Journal of Microbiology, vol. 54, no. 2, pp. 117–121, 2005. View at Google Scholar · View at Scopus
  4. S. Defres, C. Marwick, and D. Nathwani, “MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia,” European Respiratory Journal, vol. 34, no. 6, pp. 1470–1476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. D. P. Levine, “Vancomycin: understanding its past and preserving its future,” Southern Medical Journal, vol. 101, no. 3, pp. 284–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Moravvej, F. Estaji, E. Askari, K. Solhjou, M. N. Nasab, and S. Saadat, “Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains,” International Journal of Antimicrobial Agents, vol. 42, no. 4, pp. 370–371, 2013. View at Google Scholar
  7. C.-H. Huang and Y.-H. Chen, “The detection and clinical impact of vancomycin MIC among patients with methicillin-resistant Staphylococcus aureus bacteremia,” Journal of Microbiology, Immunology and Infection, vol. 46, no. 4, pp. 315–316, 2013. View at Google Scholar
  8. D. I. Hsu, L. K. Hidayat, R. Quist et al., “Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections,” International Journal of Antimicrobial Agents, vol. 32, no. 5, pp. 378–385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. C. Maltezou and H. Giamarellou, “Community-acquired methicillin-resistant Staphylococcus aureus infections,” International Journal of Antimicrobial Agents, vol. 27, no. 2, pp. 87–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Aqil, M. S. A. Khan, M. Owais, and I. Ahmad, “Effect of certain bioactive plant extracts on clinical isolates of β-lactamase producing methicillin resistant Staphylococcus aureus,” Journal of Basic Microbiology, vol. 45, no. 2, pp. 106–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. N. Eloff, “Which extractant should be used for the screening and isolation of antimicrobial components from plants?” Journal of Ethnopharmacology, vol. 60, no. 1, pp. 1–8, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Parekh and S. V. Chanda, “In vitro antimicrobial activity and phytochemical analysis of some Indian medicinal plants,” Turkish Journal of Biology, vol. 31, no. 1, pp. 53–58, 2007. View at Google Scholar · View at Scopus
  13. T. Hatano, Y. Shintani, Y. Aga, S. Shiota, T. Tsuchiya, and T. Yoshida, “Phenolic constituents of licorice. VIII. Structures of glicophenone and glicoisoflavanone, and effects of licorice phenolics on methicillin-resistant Staphylococcus aureus,” Chemical and Pharmaceutical Bulletin, vol. 48, no. 9, pp. 1286–1292, 2000. View at Google Scholar · View at Scopus
  14. T. Fukai, A. Marumo, K. Kaitou, T. Kanda, S. Terada, and T. Nomura, “Antimicrobial activity of licorice flavonoids against methicillin-resistant Staphylococcus aureus,” Fitoterapia, vol. 73, no. 6, pp. 536–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Tripoli, M. L. Guardia, S. Giammanco, D. D. Majo, and M. Giammanco, “Citrus flavonoids: molecular structure, biological activity and nutritional properties: a review,” Food Chemistry, vol. 104, no. 2, pp. 466–479, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. G. B. Mahady, “Medicinal plants for the prevention and treatment of bacterial infections,” Current Pharmaceutical Design, vol. 11, no. 19, pp. 2405–2427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Cao, Y.-J. Wei, L.-W. Qi et al., “Determination of fifteen bioactive components in Radix et Rhizoma Salviae Miltiorrhizae by high-performance liquid chromatography with ultraviolet and mass spectrometric detection,” Biomedical Chromatography, vol. 22, no. 2, pp. 164–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D.-S. Lee, S.-H. Lee, J.-G. Noh, and S.-D. Hong, “Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza bunge,” Bioscience, Biotechnology and Biochemistry, vol. 63, no. 12, pp. 2236–2239, 1999. View at Google Scholar · View at Scopus
  19. Y.-M. Ahn, S. K. Kim, S.-H. Lee et al., “Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease,” Phytotherapy Research, vol. 24, no. 12, pp. 1886–1892, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Chen, L. Liu, Y. Luo et al., “Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells,” Cancer Prevention Research, vol. 5, no. 5, pp. 778–787, 2012. View at Google Scholar
  21. H. Feng, H. Xiang, J. Zhang et al., “Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cryptotanshinone,” Journal of Biomedicine and Biotechnology, vol. 2009, Article ID 617509, 8 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-W. Lee, Y.-J. Ji, S.-O. Lee, and I.-S. Lee, “Effect of Saliva miltiorrhiza Bunge on antimicrobial activity and resistant gene regulation against Methicillin-Resistant Staphylococcus aureus (MRSA),” Journal of Microbiology, vol. 45, no. 4, pp. 350–357, 2007. View at Google Scholar · View at Scopus
  23. M. Gu, G. Zhang, Z. Su, and F. Ouyang, “Identification of major active constituents in the fingerprint of Salvia miltiorrhiza Bunge developed by high-speed counter-current chromatography,” Journal of Chromatography A, vol. 1041, no. 1-2, pp. 239–243, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. E. J. Park, H. Y. Ji, N. J. Kim et al., “Simultaneous determination of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography—tandem mass spectrometry: application to a pharmacokinetic study of a standardized fraction of Salvia miltiorrhiza, PF2401-SF,” Biomedical Chromatography, vol. 22, no. 5, pp. 548–555, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. R. D. Wojtyczka, A. Dziedzic, D. Idzik et al., “Susceptibility of Staphylococcus aureus clinical isolates to propolis extract alone or in combination with antimicrobial drugs,” Molecules, vol. 18, no. 8, pp. 9623–9640, 2013. View at Google Scholar
  26. W. Seesom, A. Jaratrungtawee, S. Suksumran, C. Mekseepralard, P. Ratananukul, and W. Sukhumsirichart, “Antileptospiral activity of xanthones from Garcinia mangostana and synergy of gamma-mangostin with penicillin G.,” BMC Complementary and Alternative Medicine, vol. 13, article 1, 2013. View at Google Scholar
  27. A. Ribeiro, A. Z. Coronado, M. C. Silva-Carvalho et al., “Detection and characterization of international community-acquired infections by methicillin-resistant Staphylococcus aureus clones in Rio de Janeiro and Porto Alegre cities causing both community- and hospital-associated diseases,” Diagnostic Microbiology and Infectious Disease, vol. 59, no. 3, pp. 339–345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Yuan, Y.-N. Pan, W.-W. Fu, T. Makino, and Y. Kano, “Quantitative analysis of the marker compounds in Salvia miltiorrihiza root and its phytomedicinal preparations,” Chemical and Pharmaceutical Bulletin, vol. 53, no. 5, pp. 508–514, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-G. Li, L. Song, M. Liu, Z.-B. Zhi-Bi-Hu, and Z.-T. Wang, “Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen),” Journal of Chromatography A, vol. 1216, no. 11, pp. 1941–1953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Zeng, H. Xiao, J. Liu, and X. Liang, “Identification of phenolic constituents in Radix Salvia miltiorrhizae by liquid chromatography/electrospray ionization mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 20, no. 3, pp. 499–506, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Jacqueline, J. Caillon, V. Le Mabecque et al., “In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods,” Journal of Antimicrobial Chemotherapy, vol. 51, no. 4, pp. 857–864, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Aiyegoro, A. Adewusi, S. Oyedemi, D. Akinpelu, and A. Okoh, “Interactions of antibiotics and methanolic crude extracts of Afzelia Africana (Smith.) against drug resistance bacterial isolates,” International Journal of Molecular Sciences, vol. 12, no. 7, pp. 4477–4487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-Y. Lee, S. O. Won, S. K. Kwan et al., “Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus,” Journal of Korean Medical Science, vol. 21, no. 2, pp. 188–192, 2006. View at Google Scholar · View at Scopus
  34. M. N. Alekshun and S. B. Levy, “Molecular mechanisms of antibacterial multidrug resistance,” Cell, vol. 128, no. 6, pp. 1037–1050, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. T.-H. Chen, Y.-T. Hsu, C.-H. Chen, S.-H. Kao, and H.-M. Lee, “Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells,” Mitochondrion, vol. 7, no. 1-2, pp. 101–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. J. D. Adams, R. Wang, J. Yang, and E. J. Lien, “Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions,” Chinese Medicine, vol. 1, article 3, 2006. View at Publisher · View at Google Scholar · View at Scopus